Gut microbiota and atrial cardiomyopathy

Area of Science:

• Cardiovascular Medicine
• Microbiology
• Gastroenterology

Background:

• Atrial cardiomyopathy involves structural and functional atrial abnormalities, often leading to atrial fibrillation.
• The gut-heart axis is increasingly recognized for its significant impact on cardiac health.
• Gut microbiota dysbiosis is implicated in various diseases, including cardiovascular conditions.

Purpose of the Study:

• To elucidate the mechanisms by which gut dysbiosis contributes to atrial cardiomyopathy.
• To explore the role of gut microbiota composition and metabolites in atrial remodeling and dysfunction.
• To review therapeutic strategies targeting the gut-heart axis for atrial cardiomyopathy.

Main Methods:

• Literature review focusing on the interplay between gut microbiota and atrial cardiomyopathy.
• Analysis of pathophysiological aspects and the impact of gut dysbiosis on atrial structure and function.
• Discussion of dietary and exercise influences on the gut microbiota in atrial cardiomyopathy.

Main Results:

• Gut microbiota dysbiosis can induce atrial remodeling and dysfunction.
• Changes in gut microbiota composition and metabolites play a role in atrial cardiomyopathy pathogenesis.
• Diet and exercise modulate the gut microbiota, influencing atrial cardiomyopathy.

Conclusions:

• Gut microbiota homeostasis is crucial for cardiovascular health.
• Targeting the gut microbiota offers potential for novel preventive and therapeutic strategies for atrial cardiomyopathy.
• Interventions like fecal microbiota transplantation, probiotics, and prebiotics show promise.